Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem CellsWhole-Body IrradiationHematopoietic Stem Cell TransplantationFetal BloodTransplantation ConditioningBone and BonesLeukemiaAnemia, AplasticTransplantation ChimeraGraft SurvivalTissue DonorsLiver TransplantationHematopoiesisHistocompatibility TestingBusulfanBone Marrow PurgingHistocompatibilityCyclophosphamideTransplantation, IsogeneicHematologic NeoplasmsBone Marrow DiseasesMice, Inbred C57BLKidney TransplantationRecurrenceLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraCombined Modality TherapyColony-Forming Units AssayAntigens, CD34Time FactorsTreatment OutcomeSpinal CordImmunosuppressive AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationRemission InductionGraft RejectionLeukemia, MyeloidCell DifferentiationHepatic Veno-Occlusive DiseaseTransplantation ImmunologyBone RemodelingStem Cell TransplantationBone Marrow NeoplasmsT-LymphocytesAcute DiseaseGraft vs Host ReactionImmunosuppressionLymphocyte DepletionHLA AntigensLymphoma, Non-HodgkinLeukocyte TransfusionSevere Combined ImmunodeficiencyChimeraMyelodysplastic SyndromesHeart TransplantationSurvival AnalysisCells, CulturedRetrospective StudiesFlow CytometryHematologic DiseasesCyclosporineLymphocyte TransfusionLung TransplantationGraft vs Leukemia EffectBone DensityActuarial AnalysisGraft vs Tumor EffectBlood CellsCord Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorCarmustineAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilySpinal Cord InjuriesSpleenFollow-Up StudiesLeukocyte CountSurvival RateCytomegalovirus InfectionsPancytopeniaGranulocytesMice, Inbred BALB CImmunophenotypingCell SeparationOrgan TransplantationHematopoietic SystemDisease-Free SurvivalAntigens, CDCytarabineMice, KnockoutCell LineageLymphoma